These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23849261)

  • 21. Recombinant human acid alpha-glucosidase (rhGAA) in adult patients with severe respiratory failure due to Pompe disease.
    Orlikowski D; Pellegrini N; Prigent H; Laforêt P; Carlier R; Carlier P; Eymard B; Lofaso F; Annane D
    Neuromuscul Disord; 2011 Jul; 21(7):477-82. PubMed ID: 21550241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep.
    Gore M; Brandenburg NA; Dukes E; Hoffman DL; Tai KS; Stacey B
    J Pain Symptom Manage; 2005 Oct; 30(4):374-85. PubMed ID: 16256902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Results of the French cohort of the European observational study FINDER: quality of life of patients treated with antidepressants].
    Dantchev N; Tcherny-Lessenot S; Picard H; Baraille L; Quail D
    Encephale; 2013 Apr; 39(2):101-8. PubMed ID: 23095580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Childhood Pompe disease: clinical spectrum and genotype in 31 patients.
    van Capelle CI; van der Meijden JC; van den Hout JM; Jaeken J; Baethmann M; Voit T; Kroos MA; Derks TG; Rubio-Gozalbo ME; Willemsen MA; Lachmann RH; Mengel E; Michelakakis H; de Jongste JC; Reuser AJ; van der Ploeg AT
    Orphanet J Rare Dis; 2016 May; 11(1):65. PubMed ID: 27189384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Late form of Pompe disease with glycogen storage in peripheral nerves axons.
    Fidziańska A; Ługowska A; Tylki-Szymańska A
    J Neurol Sci; 2011 Feb; 301(1-2):59-62. PubMed ID: 21109266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prevalence and impact of scoliosis in Pompe disease: lessons learned from the Pompe Registry.
    Roberts M; Kishnani PS; van der Ploeg AT; Müller-Felber W; Merlini L; Prasad S; Case LE
    Mol Genet Metab; 2011 Dec; 104(4):574-82. PubMed ID: 21930409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early detection of Pompe disease by newborn screening is feasible: results from the Taiwan screening program.
    Chien YH; Chiang SC; Zhang XK; Keutzer J; Lee NC; Huang AC; Chen CA; Wu MH; Huang PH; Tsai FJ; Chen YT; Hwu WL
    Pediatrics; 2008 Jul; 122(1):e39-45. PubMed ID: 18519449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac evaluation in children and adults with Pompe disease sharing the common c.-32-13T>G genotype rarely reveals abnormalities.
    van der Beek NA; Soliman OI; van Capelle CI; Geleijnse ML; Vletter WB; Kroos MA; Reuser AJ; Frohn-Mulder IM; van Doorn PA; van der Ploeg AT
    J Neurol Sci; 2008 Dec; 275(1-2):46-50. PubMed ID: 18757064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyaluronidase increases the biodistribution of acid alpha-1,4 glucosidase in the muscle of Pompe disease mice: an approach to enhance the efficacy of enzyme replacement therapy.
    Matalon R; Surendran S; Campbell GA; Michals-Matalon K; Tyring SK; Grady J; Cheng S; Kaye E
    Biochem Biophys Res Commun; 2006 Nov; 350(3):783-7. PubMed ID: 17027913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pompe disease (glycogen storage disease type II): clinical features and enzyme replacement therapy.
    van der Beek NA; Hagemans ML; van der Ploeg AT; Reuser AJ; van Doorn PA
    Acta Neurol Belg; 2006 Jun; 106(2):82-6. PubMed ID: 16898258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for Pompe disease using a rapid dried blood spot method: experience of a clinical diagnostic laboratory.
    Goldstein JL; Young SP; Changela M; Dickerson GH; Zhang H; Dai J; Peterson D; Millington DS; Kishnani PS; Bali DS
    Muscle Nerve; 2009 Jul; 40(1):32-6. PubMed ID: 19533645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mass spectrometric quantification of glycogen to assess primary substrate accumulation in the Pompe mouse.
    Fuller M; Duplock S; Turner C; Davey P; Brooks DA; Hopwood JJ; Meikle PJ
    Anal Biochem; 2012 Feb; 421(2):759-63. PubMed ID: 22239964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pompe disease: a neuromuscular disease with respiratory muscle involvement.
    Mellies U; Lofaso F
    Respir Med; 2009 Apr; 103(4):477-84. PubMed ID: 19131232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations in the acid alpha-glucosidase gene (M. Pompe) in a patient with an unusual phenotype.
    Anneser JM; Pongratz DE; Podskarbi T; Shin YS; Schoser BG
    Neurology; 2005 Jan; 64(2):368-70. PubMed ID: 15668445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors affecting health-related quality of life assessed with the SF-36v2 health survey in outpatients with chronic-stage ischemic stroke in Japan--cross-sectional analysis of the OASIS study.
    Shinohara Y;
    Cerebrovasc Dis; 2010; 29(4):361-71. PubMed ID: 20145390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p.[G576S; E689K]: pathogenic combination or polymorphism in Pompe disease?
    Kroos MA; Mullaart RA; Van Vliet L; Pomponio RJ; Amartino H; Kolodny EH; Pastores GM; Wevers RA; Van der Ploeg AT; Halley DJ; Reuser AJ
    Eur J Hum Genet; 2008 Aug; 16(8):875-9. PubMed ID: 18301443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eight years experience with enzyme replacement therapy in two children and one adult with Pompe disease.
    van Capelle CI; Winkel LP; Hagemans ML; Shapira SK; Arts WF; van Doorn PA; Hop WC; Reuser AJ; van der Ploeg AT
    Neuromuscul Disord; 2008 Jun; 18(6):447-52. PubMed ID: 18508267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Juvenile onset acid maltase deficiency presenting as a rigid spine syndrome.
    Kostera-Pruszczyk A; Opuchlik A; Lugowska A; Nadaj A; Bojakowski J; Tylki-Szymanska A; Kaminska A
    Neuromuscul Disord; 2006 Apr; 16(4):282-5. PubMed ID: 16531044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe course of glycogen storage disease type II (Pompe's disease) without development of cardiomegalia.
    Ullrich K; Gröbe H; Korinthenberg R; von Bassewitz DB
    Pathol Res Pract; 1986 Oct; 181(5):627-32. PubMed ID: 2947052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complete correction of acid alpha-glucosidase deficiency in Pompe disease fibroblasts in vitro, and lysosomally targeted expression in neonatal rat cardiac and skeletal muscle.
    Pauly DF; Johns DC; Matelis LA; Lawrence JH; Byrne BJ; Kessler PD
    Gene Ther; 1998 Apr; 5(4):473-80. PubMed ID: 9614571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.